UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Prospective analysis of 895 patients on a UK Genomics Review Board

Moore, DA; Kushnir, M; Mak, G; Winter, H; Curiel, T; Voskoboynik, M; Moschetta, M; ... Arkenau, HT; + view all (2019) Prospective analysis of 895 patients on a UK Genomics Review Board. ESMO Open , 4 (2) , Article e000469. 10.1136/esmoopen-2018-000469. Green open access

[img]
Preview
Text
Forster _Prospective analysis of 895 patients on a UK Genomics Review Board_VoR (1).pdf - ["content_typename_Published version" not defined]

Download (699kB) | Preview

Abstract

Background The increasing frequency and complexity of cancer genomic profiling represents a challenge for the oncology community. Results from next-generation sequencing-based clinical tests require expert review to determine their clinical relevance and to ensure patients are stratified appropriately to established therapies or clinical trials. Methods The Sarah Cannon Research Institute UK/UCL Genomics Review Board (GRB) was established in 2014 and represents a multidisciplinary team with expertise in molecular oncology, clinical trials, clinical cancer genetics and molecular pathology. Prospective data from this board were collated. Results To date, 895 patients have been reviewed by the GRB, of whom 180 (20%) were referred for clinical trial screening and 62 (7%) received trial therapy. For a further 106, a clinical trial recommendation was given. Conclusions Numerous challenges are faced in implementing a GRB, including the identification of potential germline variants, the interpretation of variants of uncertain significance and consideration of the technical limitations of pathology material when interpreting results. These challenges are likely to be encountered with increasing frequency in routine practice. This GRB experience provides a model for the multidisciplinary review of molecular profiling data and for the linking of molecular analysis to clinical trial networks.

Type: Article
Title: Prospective analysis of 895 patients on a UK Genomics Review Board
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/esmoopen-2018-000469
Publisher version: https://doi.org/10.1136/esmoopen-2018-000469
Language: English
Additional information: This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology
URI: http://discovery.ucl.ac.uk/id/eprint/10071932
Downloads since deposit
37Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item